Tianjin Ringpu Bio-TechnologyLtd Balance Sheet Health
Financial Health criteria checks 5/6
Tianjin Ringpu Bio-TechnologyLtd has a total shareholder equity of CN¥5.0B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 25.7%. Its total assets and total liabilities are CN¥7.4B and CN¥2.5B respectively. Tianjin Ringpu Bio-TechnologyLtd's EBIT is CN¥361.4M making its interest coverage ratio 12.3. It has cash and short-term investments of CN¥1.7B.
Key information
25.7%
Debt to equity ratio
CN¥1.27b
Debt
| Interest coverage ratio | 12.3x |
| Cash | CN¥1.69b |
| Equity | CN¥4.96b |
| Total liabilities | CN¥2.48b |
| Total assets | CN¥7.44b |
Recent financial health updates
These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well
Oct 30
Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly
Jun 26Recent updates
Solid Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)
Nov 05These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well
Oct 30The Market Lifts Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares 36% But It Can Do More
Oct 08Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Aug 26Improved Earnings Required Before Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares Find Their Feet
Aug 23Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly
Jun 26Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)
Apr 05Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity
Mar 28Financial Position Analysis
Short Term Liabilities: 300119's short term assets (CN¥3.3B) exceed its short term liabilities (CN¥1.7B).
Long Term Liabilities: 300119's short term assets (CN¥3.3B) exceed its long term liabilities (CN¥736.6M).
Debt to Equity History and Analysis
Debt Level: 300119 has more cash than its total debt.
Reducing Debt: 300119's debt to equity ratio has increased from 21% to 25.7% over the past 5 years.
Debt Coverage: 300119's debt is well covered by operating cash flow (42.2%).
Interest Coverage: 300119's interest payments on its debt are well covered by EBIT (12.3x coverage).